0
NPS Score
VS
Pfizer Claimed Company
- EMPLOYEE
PARTICIPANTS - 768
- TOTAL
RATINGS
US Oncology
- EMPLOYEE
PARTICIPANTS - 79
- TOTAL
RATINGS
Pfizer vs US Oncology
Compare Pfizer versus US Oncology for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 768 employees and customers of Pfizer and 79 employees and customers of US Oncology.
Pfizer
Pfizer's brand is ranked #214 in the list of Global Top 1000 Brands, as rated by customers of Pfizer. Their current market cap is $191.43B.
US Oncology
US Oncology's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of US Oncology.
3.2/5
Product Quality
3.1/5
3.1/5
Pricing
2.8/5
3.1/5
Customer Service
2.7/5
| 42% | Promoters |
|---|---|
| 16% | Passive |
| 42% | Detractors |
Net Promoter Score
Winner by 27
-27
NPS Score
| 33% | Promoters |
|---|---|
| 7% | Passive |
| 60% | Detractors |
See how Pfizer compares to its competitors
Working at Pfizer vs Working at US Oncology
73 / 100
CEO Rating
Winner by 16%
57 / 100
CEO Rating
Pfizer
Pfizer doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
US Oncology
Employees at US Oncology rate their CEO, Bruno Strigini, 57/100. This score is 16% lower than the scores of Pfizer's CEO, Albert Bourla. Employees in the Operations department rate Bruno Strigini the highest.